TABLE 1.

Patient Characteristics

Characteristic	Data
Age (y)	72 (56–81)
Time since diagnosis of PCa (y)	7 (0.6–21)
PSA at diagnosis (ng/mL)	36 (2.5–308)
Gleason score at diagnosis*
<8	7 (44%)
≥8	8 (50%)
T stage at diagnosis*
T1	1 (6%)
T2	11 (66%)
T3	3 (18%)
M status at diagnosis†
M0	15 (94%)
M1	1 (6%)
Primary treatment‡
Prostatectomy ± lymphadenectomy	7 (49%)
Local radiotherapy	6 (42%)
Systemic treatment	1 (7%)
Salvage treatment
None	9 (56%)
Radiotherapy	3 (19%)
Systemic treatment	4 (25%)
Indication for scan
Primary staging	2 (12%)
Biochemical recurrence	7 (42%)
Metastatic restaging	7 (42%)
PSA at time of PSMA (ng/mL)	6.2 (0.2–53.7)

^*Data missing for 1 patient.

^† M1 was defined as metastatic disease (distant metastases).

^‡ Data missing for 2 patients.

Qualitative data are number and percentage (total n = 16); continuous data are median and range.